(Q48502246)

12 February 2018

title

Synthesis and preclinical evaluation of [¹⁸F]FCHC for neuroimaging of fatty acid amide hydrolase. (English)

1 reference

12 February 2018

0 references

0 references

1 reference

Timothy M Shoup

1

1 reference

12 February 2018

Ali A Bonab

series ordinal

2

1 reference

12 February 2018

Alan A Wilson

series ordinal

3

1 reference

12 February 2018

Neil Vasdev

series ordinal

4

1 reference

12 February 2018

publication date

1 April 2015

1 reference

12 February 2018

Molecular Imaging and Biology

published in

1 reference

12 February 2018

volume

17

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

257-263

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s11307-014-0789-1

exact match

0 references

cites work

Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Structure and function of fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Endocannabinoids in the treatment of mood disorders: evidence from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

The endocannabinoid system and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Mapping human brain fatty acid amide hydrolase activity with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Column-switching HPLC for the analysis of plasma in PET imaging studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0789-1

11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.

21 January 2018

1 reference

12 December 2020

FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration

1 reference

12 December 2020

PET radiopharmaceuticals for probing enzymes in the brain

1 reference

12 December 2020

Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system

1 reference

12 December 2020

10.1007/S11307-014-0789-1

Identifiers

DOI

1 reference

12 February 2018

release_2eaopxjgezce7dxvujcquby4i4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2eaopxjgezce7dxvujcquby4i4

24 November 2022

mapped directly with Wikidata item

1 reference

12 February 2018